GLP-1 'top tips' on TikTok: what holds up and what doesn't

What did @its.me.jeannette actually say?

Jeannette offered a ten-point list for GLP-1 users whose weight loss has stalled. Her tips covered sleep, calorie intake, protein, fiber, electrolytes, resistance training, injection site rotation, not relying on the scale, and dose escalation. She was upfront that she is not giving medical advice and that results differ by person. That transparency is worth noting before we get into the weeds.

The specific claims worth examining: she recommended 40-50 grams of fiber daily, suggested that rotating injection sites can restart stalled weight loss, said "the majority will lose on higher doses" based on studies, and advised switching GLP-1 medications if one does not work. She also briefly mentioned "clear protein" added to water, which is a product category worth scrutinizing on its own.

Does the science back this up?

Mostly yes, with some notable exceptions. The core recommendations, protein preservation, resistance training, adequate sleep, and calorie adequacy, are well-supported. The injection site rotation claim is where things get shakier.

On protein: a 2022 meta-analysis by Stokes et al. in Nutrients confirmed that higher protein intake during caloric restriction preserves lean mass. GLP-1 medications suppress appetite broadly, meaning users often under-eat protein specifically, making Jeannette's prioritization advice genuinely useful.

On sleep: Spiegel et al. (2004, Annals of Internal Medicine) showed sleep deprivation raises ghrelin and lowers leptin, directly undermining appetite regulation. For someone already on a GLP-1, poor sleep can blunt the medication's effectiveness by working against its hormonal environment.

On dose escalation: the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) for tirzepatide and the STEP trials for semaglutide both showed dose-dependent weight loss responses. Her claim that "the majority will lose on higher doses" is a reasonable reading of that data, though it simplifies a more complicated picture around tolerability and individual variation.

On injection site rotation affecting efficacy: the evidence here is thin. Absorption rates do vary slightly by site, but there are no robust clinical trials demonstrating that rotating sites breaks a weight loss plateau. This is anecdotal at best.

What did they get wrong (or right)?

The 40-50 grams of fiber recommendation is aggressive. Current guidelines from the Academy of Nutrition and Dietetics set targets at 25 grams for women and 38 grams for men. Jumping to 50 grams without adequate hydration can worsen the constipation and bloating that GLP-1 users already commonly experience. That is not a trivial side effect to make worse.

The injection site rotation tip is the weakest claim in the video. Jeannette says switching from her stomach to other sites "would usually help to get things going," framing it as a plateau-breaker. There is no peer-reviewed evidence supporting this mechanism for weight loss stalls. Plateaus are metabolic events, not absorption location problems. This one falls into the category of plausible-sounding but unverified.

What she got right, and clearly: the advice to not rely solely on the scale is genuinely good. Body composition can shift significantly while scale weight stays flat, particularly during resistance training. Weekly measurements and photos are tools that behavioral research supports for sustaining motivation (Burke et al., 2011, Journal of the Academy of Nutrition and Dietetics).

Her point about switching GLP-1 medications if one does not work is also reasonable. Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide acts primarily on GLP-1 receptors. Individual receptor response genuinely varies, and switching has clinical precedent.

What should you actually know?

GLP-1 plateau advice from social media, even well-intentioned advice, cannot account for the clinical variables that actually drive non-response. Thyroid function, insulin resistance severity, medication interactions, and genetic factors in GLP-1 receptor expression all matter. A creator sharing personal experience is not a substitute for a provider reviewing your labs.

The fiber recommendation specifically warrants a conversation with your care team before you act on it. GLP-1 medications already slow gastric emptying. Adding very high fiber intake without careful titration can compound gastrointestinal side effects significantly.

On the dose escalation point: she is right that clinical trials show higher doses produce more weight loss on average. But dose decisions belong in a clinical conversation, not a TikTok comment section. If you feel your current dose is not working, that is exactly the conversation to have with your prescriber, not something to self-manage based on a video.

The overall structure of her advice, sleep, protein, resistance training, managing expectations, is consistent with what the clinical literature recommends as adjunct lifestyle support for GLP-1 therapy. The injection site rotation tip should be treated as anecdote, not protocol.